Illinois researchers developed nanoparticles that can target cancer stem cells (yellow), the rare cells within a tumor (blue) that can cause cancer to recur or spread.
Carle Illinois researchers developed nanoparticles that can target cancer stem cells, the rare cells within a tumor that can cause cancer to recur or spread.
Illinois researchers are testing the safety of a new cancer drug in a clinical trial for humans with late-stage brain cancer.
Meet Judith L. Rowen, M.D., our first permanent associate dean for academic affairs.
Professor Dipanjan Pan and Carle ophthalmologist Leanne Labriola, DO, have developed a device called OcuCheck, which recently resulted in Phase II funding from the National Science Foundation.
Dr. King Li, inaugural dean of the Carle Illinois College of Medicine, has a message for prospective students interested in joining our first class of future physician-innovators. Watch the video.
We’ve achieved preliminary accreditation from the LCME and are now actively recruiting our first class with full four-year scholarships.
Substituting foods low in saturated fat may not be as beneficial for high cholesterol and weight loss as previously thought, suggests a new study co-authored by assistant professor Dr. Margarita Teran-Garcia.
New Cancer Center at Illinois Unites Powerhouse Programs, Facilities, and Researchers.
Blair Rowitz, MD, and Jarrod Almaroad, MD, join the Carle Illinois College of Medicine with permanent appointments on the senior leadership team.